<SEC-DOCUMENT>0001714899-26-000081.txt : 20260618
<SEC-HEADER>0001714899-26-000081.hdr.sgml : 20260618
<ACCEPTANCE-DATETIME>20260618080146
ACCESSION NUMBER:		0001714899-26-000081
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260612
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260618
DATE AS OF CHANGE:		20260618

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Denali Therapeutics Inc.
		CENTRAL INDEX KEY:			0001714899
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				463872213
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38311
		FILM NUMBER:		261100473

	BUSINESS ADDRESS:	
		STREET 1:		161 OYSTER POINT BLVD.
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 866-8547

	MAIL ADDRESS:	
		STREET 1:		161 OYSTER POINT BLVD.
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dnli-20260612.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e8a4e-d200-7d8e-9a7e-4f19df28b9e3,g:0559cab7-a195-455b-b76c-b6bf9cc95d65,d:4e95b15a31a5426db4c7f071bb4ffaf1-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dnli-20260612</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001714899</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dnli-20260612.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001714899</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-06-12</xbrli:startDate><xbrli:endDate>2026-06-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4e95b15a31a5426db4c7f071bb4ffaf1_1"></div><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:20pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:20pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): </span></div><div style="margin-bottom:2pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">June 12, 2026</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Denali Therapeutics Inc.</ix:nonNumeric></span></div><div style="margin-bottom:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.040%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.040%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.774%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38311</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">46-3872213</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">incorporation)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File Number)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">161 Oyster Point Blvd.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">South San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">94080</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">650</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">866-8547</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="margin-bottom:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last reports)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.966%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol (s) </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">DNLI</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.040%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:73.828%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    &#9744;</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.639%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4e95b15a31a5426db4c7f071bb4ffaf1_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item&#160;1.01 &#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 12, 2026, Denali Therapeutics Inc. (the &#8220;Company&#8221;) entered into an asset purchase agreement (the &#8220;PRV Transfer Agreement&#8221;), pursuant to which the Company agreed to sell its Rare Pediatric Disease Priority Review Voucher (&#8220;PRV&#8221;). The Company was awarded the voucher under a U.S. Food and Drug Administration (&#8220;FDA&#8221;) program intended to encourage the development of certain rare pediatric disease product applications. The Company received the PRV when AVLAYAHTM (tividenofusp alfa) was approved by the FDA for the treatment of Hunter syndrome (mucopolysaccharidosis type II; MPS II) in March 2026. Pursuant to the PRV Transfer Agreement, the buyer agreed to pay the Company $195 million, payable in cash, upon the closing of the sale.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PRV Transfer Agreement contains customary representations, warranties, covenants, and indemnification provisions subject to certain limitations. The transaction remains subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the PRV Transfer Agreement does not purport to be complete and is qualified in its entirety by the full text of the PRV Transfer Agreement, which will be filed as an exhibit to a subsequent filing with the Securities and Exchange Commission (SEC).</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#8201;7.01&#160;&#160;&#160;&#160;Regulation FD Disclosure</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2026, the Company issued a press release announcing the matters disclosed in this report. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.</span></div><div><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160; Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:103%">(d)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Exhibits</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:72.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:83%">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:83%">Description</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:83%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pressreleasedatedjune182026.htm">Press Release dated June 18, 2026</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:83%">104</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Cover Page Interactive Data File (formatted as Inline XBRL)</span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4e95b15a31a5426db4c7f071bb4ffaf1_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="text-align:justify;text-indent:37pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DENALI THERAPEUTICS INC.</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 18, 2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Alexander O. Schuth</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexander O. Schuth, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating and Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressreleasedatedjune182026.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i55eb3fcb56a1401396cdbffc6abf255d_1"></div><div style="min-height:40.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  Exhibit 99.1</font></div><div><font><br></font></div></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.717%"><tr><td style="width:1.0%"></td><td style="width:35.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.759%"></td><td style="width:0.1%"></td></tr><tr style="height:57pt"><td colspan="3" style="padding:0 1pt;vertical-align:bottom"><div><img alt="denali_greenlogo1.jpg" src="denali_greenlogo1.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:211px"></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:112%">Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:112%">Priority Review Voucher for $195 Million  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Aptos',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:12.37pt">Proceeds from transaction to support advancement of Denali&#8217;s broad TransportVehicle&#8482;-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Aptos',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:12.37pt">Denali was awarded Priority Review Voucher following FDA approval of AVLAYAH&#8482;, the first FDA-approved biologic specifically designed to cross blood-brain barrier</font></div><div style="margin-top:10pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SOUTH SAN FRANCISCO, Calif., &#8211; June 18, 2026 &#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Denali Therapeutics Inc. (Nasdaq&#58; DNLI) today announced it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $195 million. The U.S. Food and Drug Administration (FDA) awarded the PRV to Denali following accelerated approval of the enzyme replacement therapy AVLAYAH&#8482; (tividenofusp alfa-eknm) for the treatment of Hunter syndrome (mucopolysaccharidosis type II&#59; MPS II) in March 2026. AVLAYAH is the first FDA-approved medicine in an emerging class of biotherapeutics designed to cross the blood-brain barrier via transferrin receptor (TfR)-mediated transport.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#34;The Priority Review Voucher program is an important and effective mechanism to support the development of medicines for rare pediatric diseases. Monetizing this PRV strengthens our financial flexibility at a pivotal moment as we build on the momentum created by the FDA approval of AVLAYAH, the first FDA-approved biotherapeutic designed to reach the whole body, including the brain,&#34; said Alexander Schuth, M.D., Chief Operating and Financial Officer of Denali Therapeutics. &#34;The proceeds will fuel the advancement and acceleration of our broad clinical pipeline, including additional Enzyme TransportVehicle programs for lysosomal storage disorders and Oligonucleotide and Antibody TransportVehicle programs targeting Alzheimer's and other neurodegenerative diseases.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Denali's clinical-stage portfolio includes DNL126 (ETV&#58;SGSH) for Sanfilippo syndrome type A (MPS IIIA), DNL593 (PTV&#58;PGRN) for </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">GRN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">-related frontotemporal dementia, DNL952 (ETV&#58;GAA) for Pompe disease and DNL628 (OTV&#58;MAPT) for Alzheimer's disease. Denali also has multiple programs in the Investigational New Drug (IND)-enabling stage, including DNL921 (ATV&#58;Abeta) for Alzheimer's disease, DNL111 (ETV&#58;GCase) for Parkinson's disease and Gaucher disease, DNL622 (ETV&#58;IDUA) for Hurler syndrome (MPS I) and DNL422 (OTV&#58;SNCA) for Parkinson's disease.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The PRV transaction is subject to customary closing conditions, including expiration of the applicable waiting period under the Hart-Scott Rodino Antitrust Improvements Act.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">About the Denali TransportVehicle</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Platform</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The blood-brain barrier (BBB) is essential in maintaining the brain&#8217;s microenvironment and protecting it from harmful substances and pathogens circulating in the bloodstream. Historically, the BBB has posed significant challenges to drug development for central nervous system diseases by preventing most drugs from reaching the brain in therapeutically relevant concentrations. Denali&#8217;s TransportVehicle</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (TV) platform is a proprietary technology designed to effectively deliver large therapeutic molecules such as antibodies, enzymes and oligonucleotides throughout the whole body, including the brain, by crossing the BBB after intravenous administration. The TV platform is based on engineered Fc domains that bind to specific natural transport receptors, such as transferrin receptor and CD98 heavy chain amino acid transporter, which are expressed at the BBB and deliver the TV and its therapeutic cargo to the brain through receptor-mediated transcytosis. In animal models, antibodies and enzymes engineered with the TV platform demonstrate more than 10- to 30-fold greater brain exposure than similar antibodies and enzymes without this technology. Oligonucleotides engineered with the TV platform demonstrate more than a 1,000-fold greater brain exposure in primates than systemically delivered oligonucleotides without this technology. Improved exposure and broad distribution in the brain may increase therapeutic efficacy by enabling widespread achievement of therapeutically relevant concentrations of product candidates. The TV platform has been clinically validated, with AVLAYAH&#8482; (tividenofusp alfa-eknm) as the first FDA-approved medicine leveraging transferrin receptor to cross the BBB.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#4f81bd;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">About Denali Therapeutics</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Denali Therapeutics Inc. is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier (BBB) using its proprietary TransportVehicle&#8482; platform. With the first FDA-approved biologic specifically designed to cross the BBB, a clinically validated delivery platform and a growing portfolio of therapeutic candidates across all stages of development, Denali is advancing toward its goal of delivering effective medicines to transform life for people with neurodegenerative diseases, lysosomal storage disorders and other serious diseases. For more information, please visit </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">www.denalitherapeutics.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements expressed or implied in this press release include, but are not limited to, statements regarding the timeline and likelihood of satisfying closing conditions for, and consummating the sale of, the Priority Review Voucher (&#8220;PRV&#8221;)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">expected use of proceeds from the sale of the PRV and the anticipated impact on Denali's cash runway&#59; plans, timelines and expectations related to Denali's Enzyme TransportVehicle&#8482; (ETV) franchise and its therapeutic and commercial potential&#59; plans, timelines and expectations related to AVLAYAH&#8482; (tividenofusp alfa-eknm)&#59; and statements by Denali&#8217;s Chief Operating and Financial Officer. Actual results may differ materially from those expressed or implied by these forward-looking statements due to a variety of risks and uncertainties. These include, but are not limited to, uncertainties related to the FDA&#8217;s policies and accelerated approval program&#59; risks arising from adverse economic conditions and their impact on Denali&#8217;s business and operations&#59; the possibility of events or changes that could lead to the termination of Denali&#8217;s collaboration agreements&#59; challenges associated with Denali&#8217;s transition to a commercial company&#59; the ability of Denali and its collaborators to complete the development and, if approved, the commercialization of product candidates&#59; difficulties in patient enrollment for ongoing and future clinical trials&#59; whether the current ongoing trials have been powered sufficiently to demonstrate approvability to regulatory agencies&#59; reliance on third-party manufacturers and suppliers for clinical trial materials&#59; dependence on the successful development of Denali&#8217;s blood-brain barrier platform technology and related programs&#59; potential delays or failures in meeting expected clinical trial timelines&#59; the risk that promising preclinical profiles may not be replicated in clinical settings&#59; discrepancies between preclinical, early-stage or preliminary clinical results and outcomes from later-stage trials&#59; the occurrence of significant adverse events or other undesirable side effects&#59; the uncertainty surrounding regulatory approvals required for commercialization in the U.S., Europe or other international jurisdictions&#59; Denali&#8217;s ability to advance a pipeline of product candidates or develop commercially successful products&#59; developments relating to Denali's competitors and its industry, including competing product candidates and therapies&#59; Denali&#8217;s ability to obtain, maintain or protect intellectual property rights related to its product candidates&#59; the implementation and success of Denali&#8217;s strategic plans for its business, product candidates and blood-brain barrier platform technology&#59; Denali's ability to obtain additional capital to finance its operations, as needed&#59; Denali's ability to accurately forecast future financial results in the current environment&#59; and other risks and uncertainties, including those described in Denali's most recent Annual and Quarterly Reports on Forms 10-K and 10-Q filed with the Securities and Exchange Commission (SEC) on February 26, 2026 and May 7, 2026, respectively, and Denali&#8217;s future reports to be filed with the SEC. Except for AVLAYAH, Denali's product candidates are investigational, and their safety and efficacy profiles have not yet been established. Denali does not undertake any obligation to update or revise any forward-looking statements, to conform these statements to actual results or to make changes in Denali&#8217;s expectations, except as required by law.</font></div><div style="margin-top:10pt"><font><br></font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Laura Hansen</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">hansen&#64;dnli.com</font></div><div style="margin-top:10pt"><font><br></font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Media Contact&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Erin Patton</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">epatton&#64;dnli.com</font></div><div style="margin-top:10pt"><font><br></font></div><div><font><br></font></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>dnli-20260612.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e8a4e-d200-7d8e-9a7e-4f19df28b9e3,g:0559cab7-a195-455b-b76c-b6bf9cc95d65-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dnli="http://www.denalitherapeutics.com/20260612" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.denalitherapeutics.com/20260612">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dnli-20260612_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dnli-20260612_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.denalitherapeutics.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>dnli-20260612_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e8a4e-d200-7d8e-9a7e-4f19df28b9e3,g:0559cab7-a195-455b-b76c-b6bf9cc95d65-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_019e8a4e-d200-76b1-bb31-2fb9d7c24871_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_019e8a4e-d200-7180-8512-bdd311598afd_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019e8a4e-d200-7fa8-8b77-78d7ff3245b3_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019e8a4e-d200-7846-abe7-7037d6dc91fd_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_019e8a4e-d200-7002-a67e-8650493ff0e1_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019e8a4e-d200-7ff4-9a78-1ef1ae41f8b7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019e8a4e-d200-71ef-9e98-4b4f487af4d9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_019e8a4e-d200-719a-902f-1ab6b773b466_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019e8a4e-d200-7890-b644-b0c267f9d073_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019e8a4e-d200-748f-a1a4-3b52be1299cf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019e8a4e-d200-7359-95cc-ad3cb000a8d5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019e8a4e-d200-7cba-9f14-ce4e09458bb5_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019e8a4e-d200-7c90-8959-2c4060371477_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019e8a4e-d200-76ba-a070-34660cda8aeb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019e8a4e-d200-770e-9617-ae5f1b44e28b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019e8a4e-d200-7e43-b5d9-d1f7a62f3a9f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019e8a4e-d200-7063-a219-92686a60ae90_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019e8a4e-d200-783e-93e5-bd787b46207f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019e8a4e-d200-780e-988f-3a9f93567616_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019e8a4e-d200-7a97-b2cf-3223fcb1b8f0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019e8a4e-d200-7c6a-b9c8-a46c8eb30f3c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019e8a4e-d200-7ed6-904e-728ce3f110aa_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>dnli-20260612_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e8a4e-d200-7d8e-9a7e-4f19df28b9e3,g:0559cab7-a195-455b-b76c-b6bf9cc95d65-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/Cover" xlink:type="simple" xlink:href="dnli-20260612.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.denalitherapeutics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019e8a4e-d200-74ff-8f1d-a1ba38e229fa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_DocumentType_019e8a4e-d200-74ff-8f1d-a1ba38e229fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019e8a4e-d200-79dd-a981-8172a022102d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_DocumentPeriodEndDate_019e8a4e-d200-79dd-a981-8172a022102d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019e8a4e-d200-7eee-bb66-ecc6e3ce8188" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityRegistrantName_019e8a4e-d200-7eee-bb66-ecc6e3ce8188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019e8a4e-d200-7c34-a5ba-1b5d588bb9ee" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019e8a4e-d200-7c34-a5ba-1b5d588bb9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019e8a4e-d200-7947-a0d9-653f08f60b72" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityFileNumber_019e8a4e-d200-7947-a0d9-653f08f60b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019e8a4e-d200-707b-bb66-bf7ca1702248" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityTaxIdentificationNumber_019e8a4e-d200-707b-bb66-bf7ca1702248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019e8a4e-d200-7896-9f04-d8033e13e98d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityAddressAddressLine1_019e8a4e-d200-7896-9f04-d8033e13e98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019e8a4e-d200-73cb-9c72-8672043b69f4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityAddressCityOrTown_019e8a4e-d200-73cb-9c72-8672043b69f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019e8a4e-d200-79bb-9d18-8eb5da32d933" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityAddressStateOrProvince_019e8a4e-d200-79bb-9d18-8eb5da32d933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019e8a4e-d200-75f1-9e5b-2659738e4d4e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityAddressPostalZipCode_019e8a4e-d200-75f1-9e5b-2659738e4d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019e8a4e-d200-79bb-a60d-8963cf437d21" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_CityAreaCode_019e8a4e-d200-79bb-a60d-8963cf437d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019e8a4e-d200-78d5-a45e-fe75f6d51a12" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_LocalPhoneNumber_019e8a4e-d200-78d5-a45e-fe75f6d51a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019e8a4e-d200-7d6e-8752-688573c83e28" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_WrittenCommunications_019e8a4e-d200-7d6e-8752-688573c83e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019e8a4e-d200-783a-9396-c531a8f0c54f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_SolicitingMaterial_019e8a4e-d200-783a-9396-c531a8f0c54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019e8a4e-d200-7960-9fcc-5a46fa56c8b5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_PreCommencementTenderOffer_019e8a4e-d200-7960-9fcc-5a46fa56c8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019e8a4e-d200-729a-9475-9a6943c34f02" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019e8a4e-d200-729a-9475-9a6943c34f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019e8a4e-d200-775f-be27-51ba9a053332" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityEmergingGrowthCompany_019e8a4e-d200-775f-be27-51ba9a053332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019e8a4e-d200-77da-8b2b-0425148e5fa6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_TradingSymbol_019e8a4e-d200-77da-8b2b-0425148e5fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019e8a4e-d200-7ba5-82b5-083e5dd9b36a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_SecurityExchangeName_019e8a4e-d200-7ba5-82b5-083e5dd9b36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019e8a4e-d200-72b8-9ef2-87b9f90f372c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_EntityCentralIndexKey_019e8a4e-d200-72b8-9ef2-87b9f90f372c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019e8a4e-d200-710f-982a-3e3773fa3b7b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_AmendmentFlag_019e8a4e-d200-710f-982a-3e3773fa3b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019e8a4e-d200-7ee7-ad9c-87afbae8f5f0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e8a4e-d200-7a50-842d-5647d5f9023c" xlink:to="loc_dei_Security12bTitle_019e8a4e-d200-7ee7-ad9c-87afbae8f5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>denali_greenlogo1.jpg
<TEXT>
begin 644 denali_greenlogo1.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_X@_P24-#7U!23T9)3$4  0$   _@87!P
M; (0  !M;G1R4D="(%A96B 'Z0 +  0 !P 5 #AA8W-P05!03     !!4%!,
M                        ]M8  0    #3+6%P<&P
M                                             !%D97-C   !4
M &)D<V-M   !M   !+QC<')T   &<    "-W='!T   &E    !1R6%E:   &
MJ    !1G6%E:   &O    !1B6%E:   &T    !1R5%)#   &Y   " QA87)G
M   .\    "!V8V=T   /$    #!N9&EN   /0    #YM;6]D   /@    "AV
M8V=P   /J    #AB5%)#   &Y   " QG5%)#   &Y   " QA86)G   .\
M "!A86=G   .\    "!D97-C          A$:7-P;&%Y
M
M                                ;6QU8P         G    #&AR2%(
M   4   !Y&MO2U(    ,   !^&YB3D\    2   "!&ED       2   "%FAU
M2%4    4   "*&-S0UH    6   "/'-L4TD    4   "4F1A1$L    <   "
M9FYL3DP    6   "@F9I1DD    0   "F&ET250    8   "J&5S15,    6
M   "P')O4D\    2   "UF9R0T$    6   "Z&%R       4   "_G5K54$
M   <   #$FAE24P    6   #+GIH5%<    *   #1'9I5DX    .   #3G-K
M4TL    6   #7'IH0TX    *   #1')U4E4    D   #<F5N1T(    4   #
MEF9R1E(    6   #JFUS       2   #P&AI24X    2   #TG1H5$@    ,
M   #Y&-A15,    8   #\&5N054    4   #EF5S6$P    2   "UF1E1$4
M   0   $"&5N55,    2   $&'!T0E(    8   $*G!L4$P    2   $0F5L
M1U(    B   $5'-V4T4    0   $=G1R5%(    4   $AG!T4%0    6   $
MFFIA2E     ,   $L !, $, 1  @ '4 ( !B &\ :@!ISNRW[  @ $P 0P!$
M $8 80!R &< 90 M $P 0P!$ $P 0P!$ "  5P!A '( ;@!A %, >@#M &X
M90!S "  3 !# $0 0@!A '( 90!V &X _0 @ $P 0P!$ $( 80!R '8 ;@!I
M "  3 !# $0 3 !# $0 +0!F &$ <@!V &4 <P!K .8 <@!M $L ; !E '4
M<@!E &X +0!, $, 1 !6 .0 <@!I "T 3 !# $0 3 !# $0 ( !A "  8P!O
M &P ;P!R &D 3 !# $0 ( !A "  8P!O &P ;P!R $P 0P!$ "  8P!O &P
M;P!R $$ 0P!, "  8P!O '4 ; !E '4 <B / $P 0P!$ " &109$!D@&1@8I
M!!H$/@0[!$P$/@1 !#X$,@0X!#D ( !, $, 1" / $P 0P!$ " %Y@71!>(%
MU07@!=E?:8)R $P 0P!$ $P 0P!$ "  30#@ '4 1@!A '( 90!B &X _0 @
M $P 0P!$!"8$,@0U!$($/00^!#D ( 06!!H +00T!#@$000_!#L$-00Y $,
M;P!L &\ =0!R "  3 !# $0 3 !# $0 ( !C &\ =0!L &4 =0!R %< 80!R
M &X 80 @ $P 0P!$"3 ) @D7"4 )*  @ $P 0P!$ $P 0P!$ " .*@XU $P
M0P!$ "  90!N "  8P!O &P ;P!R $8 80!R &( +0!, $, 1 !# &\ ; !O
M '( ( !, $, 1 !, $, 1  @ $, ;P!L &\ <@!I &0 ;P!+ &\ ; !O '(
M( !, $, 1 .( [,#QP/! \D#O .W " #OP.X \P#O0.W "  3 !# $0 1@#D
M '( 9P M $P 0P!$ %( 90!N &L ; !I "  3 !# $0 3 !# $0 ( !A "
M8P!O '( 90!S,*LPZ3#\ $P 0P!$=&5X=     !#;W!Y<FEG:'0@07!P;&4@
M26YC+BP@,C R-0  6%E:(        /-1  $    !%LQ865H@        @]\
M #V_____NUA96B        !*OP  L3<   JY6%E:(        "@X   1"P
MR+EC=7)V        !      %  H #P 4 !D '@ C "@ +0 R #8 .P!  $4
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MWO9M]OOWBO@9^*CY./G'^E?ZY_MW_ ?\F/TI_;K^2_[<_VW__W!A<F$
M  ,    "9F8  /*G   -60  $]    I;=F-G=          !  $
M 0    $          0    $          0  ;F1I;@         V  "N%
M4>P  $/7  "PI   )F8   ]<  !0#0  5#D  C,S  (S,P ",S,
M &UM;V0        &$   H%+]8FUB                          !V8V=P
M       #     F9F  ,    "9F8  P    )F9@    (S,S0      C,S-
M   ",S,T /_N  Y!9&]B90!D      '_VP!#  P("!L*&R(1%R0J)!P;("0K
M*"@@)"DE)3$O)2DN*BLK.2LJ+B\T-34U-"\[.SL[.SL[.SL[.SL[.SL[.SL[
M.SO_VP!# 0T+"Q .$!L4&R0R*"$H,CLT,C(R.SL[.SL[.SL[.SL[.SL[.SM
M0$! 0#M 0$! 0$! 0$! 0$! 0$! 0$! 0$#_VP!# @T+"Q .$!L4&R0R*"$H
M,CLT,C(R.SL[.SL[.SL[.SL[.SL[.SM 0$! 0#M 0$! 0$! 0$! 0$! 0$!
M0$! 0$#_P  1" '%"&$# "(  1$! A$"_\0 'P   04! 0$! 0$
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M]?;W^/GZ_]H # ,   $1 A$ /P#U6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** ,K6/$46D#,IY/11RQ_"N:?XG<X6'\WP?
MRVFN3UK4FU*5I2<AB<>FT' %4:=C-R9W/_"S_P#IC_Y$_P#L:/\ A9__ $Q_
M\B?_ &-<-13L+F9W/_"S_P#IC_Y$_P#L:/\ A9__ $Q_\B?_ &-<-118.9G<
M_P#"S_\ IC_Y$_\ L:/^%G_],?\ R)_]C7#446#F9W/_  L__IC_ .1/_L:/
M^%G_ /3'_P B?_8UPU%%@YF=S_PL_P#Z8_\ D3_[&C_A9_\ TQ_\B?\ V-<-
M118.9G<_\+/_ .F/_D3_ .QH_P"%G_\ 3'_R)_\ 8UPU%%@YF=S_ ,+/_P"F
M/_D3_P"QH_X6?_TQ_P#(G_V-<-118.9G<_\ "S_^F/\ Y$_^QH_X6?\ ],?_
M ")_]C7#446#F9W/_"S_ /IC_P"1/_L:/^%G_P#3'_R)_P#8UPU%%@YF=S_P
ML_\ Z8_^1/\ [&C_ (6?_P!,?_(G_P!C7#446#F9W/\ PL__ *8_^1/_ +&C
M_A9__3'_ ,B?_8UPU%%@YF=S_P +/_Z8_P#D3_[&C_A9_P#TQ_\ (G_V-<-1
M18.9G=)\3L]83^#Y_P#915N'XD0M]Y''TP?ZBO.J,46#G9ZU9^+[:ZX60 ^C
M97^=:R2AQN!R/;G^5>'^U6K+4Y;$[HG9?H3C\CP:5BE,]HW4M<%I/Q&(^6X7
M(_O)U_$5VEEJ*7RB2)@RGN/\\4K%)W+5%%% PHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *2EI": "C-0SW2VX+N0%'4D\5R>K_$
M5(OEMQN/]YN%_ =_TH%='8!ZH7GB&"S^_(H/H#D_D,FO+]1\13ZAQ(YQ_='"
M_D/ZUFXSUY^M.Q+F>F3_ !#MH_N[F^BX_F15-_B9&.D;?B0/\:\_H%.PN=G?
M_P#"RT_YY'_OH?X4?\++3_GD?^^A_A7 8HQ2L'.SO_\ A9:?\\C_ -]#_"C_
M (66G_/(_P#?0_PK@,48HL+G9W__  LM/^>1_P"^A_A1_P ++3_GD?\ OH?X
M5P&*,46#G9W_ /PLM/\ GD?^^A_A1_PLM/\ GD?^^A_A7 8HQ18.=G?_ /"R
MT_YY'_OH?X4?\++3_GD?^^A_A7 8HQ18.=G?_P#"RT_YY'_OH?X4?\++3_GD
M?^^A_A7 8HQ18.=G?_\ "RT_YY'_ +Z'^%'_  LM/^>1_P"^A_A7 8HQ18.=
MG?\ _"RT_P">1_[Z'^%'_"RT_P">1_[Z'^%<!BC%%@YV=_\ \++3_GD?^^A_
MA1_PLM/^>1_[Z'^%<!BC%%@YV=__ ,++3_GD?^^A_A1_PLQ/^>3?]]#_  K@
M,48HL'.SO_\ A9B?\\F_[Z'^%'_"S$_YY-_WT/\ "N HHL'.SO\ _A9B?\\F
M_P"^A_A6SH_BV'53L7*OC[K\$_2O)Z?%*82'4X(.01USZT6*4F>X YI:IZ/>
M_;H4G[NH)QTSW_6KE(L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ I*#3=U #J:&K#UGQE!IN5SO<?PKS^9Z#^=<7J?CBXO,JI\M?1>I^IY_3%!
M+E8])NM1CM!F1E7_ 'B!61<^.[6#HQ;_ '5/\S@?K7ETDIE.6))]3R?SIM.Q
M/.>AR?$N$?=1S]<#^1-1?\+,7_GD?^^Q_A7 T4["YV=[_P +-7_GD?\ OL?X
M4O\ PLU?^>1_[['^%<#1BBP<[.^_X6:O_/(_]]C_  H_X6:O_/(_]]C_  K@
M<48HL'.SOO\ A9J_\\C_ -]C_"C_ (6:O_/(_P#?8_PK@<48HL'.SOO^%FK_
M ,\C_P!]C_"C_A9J_P#/(_\ ?8_PK@<48HL'.SOO^%FK_P \C_WV/\*/^%FK
M_P \C_WV/\*X'%&*+!SL[[_A9J_\\C_WV/\ "C_A9J_\\C_WV/\ "N!Q1BBP
M<[.^_P"%FK_SR/\ WV/\*/\ A9J_\\C_ -]C_"N!Q1BBP<[.^_X6:O\ SR/_
M 'V/\*/^%FK_ ,\C_P!]C_"N!Q1BBP<[.]_X6:O_ #R/_?8_PI?^%F+_ ,\C
M_P!]C_"N!HHL'.ST./XEPG[R./I@_P R*T;;QQ:S\;MI]&4C]>GZUY728I6'
MSGMEM?I=#=&RL/\ 9.?Y5/NKQ"*0PG<I(/J"0?SKH=+\=SV?RR?.HZ[N#_WU
M_C18:G<]/HS6'HWB^'5,*IVN?X6Z_@>AK:W4B]Q]%(*6@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** *UY?+9H99"%5>I-<M<?$J-#A(V(]20O^-9/Q#U RRBW_
M (8P#^)Y_D17)XII$2EJ=]_PLU?^>1_[['^%'_"S5_YY'_OL?X5P.*,4[$\[
M.^_X6:O_ #R/_?8_PH_X6:O_ #R/_?8_PK@<48HL'.SOO^%FK_SR/_?8_P *
M=%\3(R<-&P^A!_F!7G^* <46#G9Z_I7B2'4^(V^;^Z>&_+_#BM/=7A\<AB(9
M205Z$=1^->E^#_$G]JJ8Y/\ 6IU]QG@_X_\ UZ31:D=/1112*"BBB@ HHHH
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MZ8'->&X[UV?AOQT8BL%R<@]'[\],TFBXR/0:*8K[N1SGTI](L**** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8/CD9LY?\
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MZ:BBBD6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 >>_$S_61_[A_G7&UV7Q,_UD?^X?YUQM4C.6X4444$A1110 44
M44 =!X$_X^T^C_\ H)KU.O+/ G_'VGT?_P!!->IU+-(;"T444%!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !6#XX_X\Y?^ ?^AK6]6#XX_P"/.7_@'_H:
MT">QY2:*#13,@HHHI@%%%% !6[X'_P"/R+_@?_H#5A5N^!_^/R+_ ('_ .@-
M0-;GJ]%%%2:GA=%2W=N;9VB;JI(_*HJHQ"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M4\.:N=*F67/RG ;Z'K6710&Q[DK9Y[4ZN=\%ZG]NMU!^]&=I_#!'Z'^==%4F
MR=PHHHH **** "BBB@ HHHH **** "BBB@ I*6J]]="T1I6Z(I/Y4 <'\0=:
M\YQ:+T09;ZD9 _ ?SKCS4MS<M<,TK'YF))_$YJ*J,I.["BBB@04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !0!10#0!ZYX0_P"/2+_=_J:V*R_#,!@MHD;J$'Z\_P!:U*DV"BBB@ HH
MHH **** "BBB@ HHHH **** $-8OBG5_[,@9Q]YOE7ZGO^%;5>:_$#4OM$X@
M!XB X[9/)_2@3=CEV)8DGO24451D%%%% !1110 4444 %%%% !1110 4444
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M&O7:Y?QYI/VR#S5'S1<_\![C\.OX4)DR5SS2BC&>:*HS"BBB@ HHHH ****
M.@\$ZO\ 8)PK'Y9?E/L>@/Y\?2O4LFO#@V.1UKUOPSJW]IP++_$!AOJO^-)E
MP9L4444BPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** //?B9_K(_]P_SKC:[+XF?ZR/_ '#_ #KC:I&<MPHHHH)"BBB@ HHH
MH Z#P)_Q]I]'_P#037J=>6>!/^/M/H__ *":]3J6:0V%HHHH*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "L'QQ_QYR_\ _\ 0UK>K!\<?\><O_ /_0UH
M$]CRDT4&BF9!1113 **** "MWP/_ ,?D7_ __0&K"K=\#_\ 'Y%_P/\ ] :@
M:W/5Z***DU$Q12T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ"TF7 6BEHI%B44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M%
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M *":]3J6:0V%HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L'QQ_Q
MYR_\ _\ 0UK>K!\<?\><O_ /_0UH$]CRDT4&BF9!1113 **** "MWP/_ ,?D
M7_ __0&K"K=\#_\ 'Y%_P/\ ] :@:W/5Z***DU"BBB@ HHHH **** "BBB@
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M *&M;U8/CC_CSE_X!_Z&M GL>4FB@T4S(****8!1110 5N^!_P#C\B_X'_Z
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M% 'J_@?_ (\XO^!_^AM6[6%X'_X\XO\ @?\ Z&U;M2;(**** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHHH **** "BBB@#B/B9TB_X'_-*X*N]^)G2+_@?\TK@JI&<MPHHHH)"BBB@
MHHHH LZ9_K8_]]?YBO:A7BNF?ZV/_?7^8KVH4F7 6BBBD6%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 )1110!X=+U/UIM.EZGZTVJ,0HH
MHH **** "BBB@#U?P/\ \><7_ __ $-JW:PO _\ QYQ?\#_]#:MVI-D%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 )FH9[D0*7/0"I<5S_
M (EN\8A'KDU$Y\JN72ASR43"GE,Q+'JQIE%%>>]3UTK"T444AA1110 4444
M)6OX<L_-<R'HO\SR/TK(Q7::79_98PO?'/UK:A3O*YRXNKRPY>I=Q1BEHKN/
M."BBB@ HHHH **** ,CQ)I7]IP-%_%U7ZC_ZV1]#7D9&#C_/TKW'%>7^.=(^
MPS[U^[*"P] 1]X4T1-'.T444R HHHH **** "C-%% 'I7@+5_M</D-]Z+ _X
M"?N_ETKJ<UY#X9U;^S)UD)^4\-]#_AQ^5>N@YI,UB[H=1112&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!Y[\3/]9'_N'^=<;79?$S_61_[A_G
M7&U2,Y;A11102%%%% !1110!T'@3_C[3Z/\ ^@FO4Z\L\"?\?:?1_P#T$UZG
M4LTAL+11104%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8/CC_CSE_P"
M?^AK6]6#XX_X\Y?^ ?\ H:T">QY2:*#13,@HHHI@%%%% !6[X'_X_(O^!_\
MH#5A5N^!_P#C\B_X'_Z U UN>KT445)J%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q?Q+_ -7%_OG^
M5>?UZ!\2_P#5Q?[Y_E7G]4C.>X4444$A1110 4444 /M_O+]1_.O<:\.M_O+
M]1_.O<:3+AL%%%%(L**** "BBB@ HHHH **** "BBB@ KRKQU_Q]R?1/_0!7
MJM>5>.O^/N3Z)_Z *:)GL8%%%%,S"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /2?AS_Q[-_UU
M;_T%:ZH5ROPY_P"/9O\ KJW_ *"M=4*DU0M%%% PHHHH **** "BBB@ HHHH
M **** "BBB@#B/B9TB_X'_-*X*N]^)G2+_@?\TK@JI&<MPHHHH)"BBB@ HHH
MH LZ9_K8_P#?7^8KVH5XKIG^MC_WU_F*]J%)EP%HHHI%A1110 4444 %%%%
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M_4?SKW&DRX;!1112+"BBB@ HHHH **** "BBB@ HHHH *\J\=?\ 'W)]$_\
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M1>3_ $K/S^M=;H-G]G3/=L&M*$.>1SXFIR0OU9J[:,4M%>@>8%%%% !1110
M4444 %%%% !1110!S?C;2/[0@+*/GB^8>X[C\N:\OKW$IGBO(_$VE'3)VB'W
M2=R_[I_PIHB:,JBBBF0%%%% !1110 4444 >L>$]7_M.!7/WD^5OJ!U_$5MU
MY=X'U?[#/L8_)+\OT;L?YC\:]0-)FJ=T.HHHI#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#SWXF?ZR/_</\ZXVNR^)G^LC_ -P_SKC:I&<MPHHHH)"B
MBB@ HHHH Z#P)_Q]I]'_ /037J=>6>!/^/M/H_\ Z":]3J6:0V%HHHH*"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+%'^Q(/^>2?]\+_A1_8D'_/)/^^%_P *O44!8H_V)!_SR3_OA?\ "C^Q(/\
MGDG_ 'PO^%7J* L4?[$@_P">2?\ ?"_X4?V)!_SR3_OA?\*O44!8H_V)!_SR
M3_OA?\*/[$@_YY)_WPO^%7J* L4?[$@_YY)_WPO^%']B0?\ /)/^^%_PJ]10
M%BC_ &)!_P \D_[X7_"C^Q(/^>2?]\+_ (5>HH"Q1_L2#_GDG_?"_P"%']B0
M?\\D_P"^%_PJ]10%BC_8D'_/)/\ OA?\*7^Q(/\ GDG_ 'PO^%7:*!V*7]B0
M?\\D_P"^%_PJQ%;+$-J@ >@ '\JEHH ;MI<4M% !1110 4444 %%%% !1110
M 4444 %%%% !1110!Q'Q,Z1?\#_FE<%7>_$SI%_P/^:5P54C.6X4444$A111
M0 4444 6=,_UL?\ OK_,5[4*\5TS_6Q_[Z_S%>U"DRX"T444BPHHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+/ G_'VGT?\ ]!->IU+-(;"T444%!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !6#XX_X\Y?\ @'_H:UO5@^./^/.7_@'_ *&M GL>4FB@T4S(****8!11
M10 5N^!_^/R+_@?_ * U85;O@?\ X_(O^!_^@-0-;GJ]%%%2:A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 <7\2_P#5Q?[Y_E7G]>@?$O\ U<7^^?Y5Y_51,Y[A11102%%%% !1110
M^W^\OU'\Z]QKPZW^\OU'\Z]QI,N&P4444BPHHHH **** "BBB@ HHHH ****
M "O*O'7_ !]R?1/_ $ 5ZK7E7CK_ (^Y/HG_ * *:)GL8%%%%,S"BBB@ HHH
MH *[+X:?ZR3_ '!_.N-KLOAI_K)/]P?SH8X[GH-+24M2:A1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M37J=>6>!/^/M/H__ *":]3J6:0V%HHHH*"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "L'QQ_QYR_\ _\ 0UK>K!\<?\><O_ /_0UH$]CRDT4&BF9!1113
M **** "MWP/_ ,?D7_ __0&K"K=\#_\ 'Y%_P/\ ] :@:W/5Z***DU"BBB@
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M_/1_^^C_ (T?VE+_ ,]'_P"^C_C187.>TYHS7BW]I2_\]'_[Z/\ C1_:4O\
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M?^ C=7KM>>_#>QW.\YZ*H4?5N3^@_6O0J3-(+0****104444 %%%% !1110
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MX$RAUY##(/L1FO$?>O1/A]JOGQ&V)^:(\?[I_P #^F*&BX,["BBBI+"BBB@
MHHHH **** "BBB@ HHHH Y'XCVQD@60?P.,_0@C^>*\YKV'Q%8_;H)(NY7CZ
MCD5X]FFC.>X4444R0HHHH **** #ISWKIO"OB_\ LL>1+S'G@\Y7\.XKF:*
M3LSVFPU..^7?$P8>W]1VJSFO#T<QG*G!'IQ4W]I2_P!]O^^C_C2L7SGM6:,U
MXM_:4O\ ST?_ +Z/^-']I2_\]'_[Z/\ C18.<]IS1FO%O[2E_P">C_\ ?1_Q
MH_M*7_GH_P#WT?\ &BP<Y[3FC->+?VE+_P ]'_[Z/^-']I2_\]'_ .^C_C18
M.<]IS1FO%O[2E_YZ/_WT?\:/[2E_YZ/_ -]'_&BP<Y[3FC->+?VE+_ST?_OH
M_P"-']I2_P#/1_\ OH_XT6#G/:<T9KQ;^TI?^>C_ /?1_P :/[2E_P">C_\
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M4 %8/CC_ (\Y?^ ?^AK6]6#XX_X\Y?\ @'_H:T">QY2:*#13,@HHHI@%%%%
M!6[X'_X_(O\ @?\ Z U85;O@?_C\B_X'_P"@-0-;GJ]%%%2:GALDID8N>K$D
M_CUIM%%48A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 48HK:\(Z+_:<XSRD>&;TX/ _'
MI^?I0.UV=]X2TS[!;HA^\PW-]6YQ^ K<INVG5)J%%%% !1110 4444 %%%%
M!1110 4444 %07=N+A6C;HP(/X\5/24 >)7EHUK(T+=48@_A_CU^E0UV?Q#T
M<JPO%Z-A6QV(Z'\1Q^ ]:XRJ1DU9A1110(**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HS110!Z_P"%
MIC-:Q,W78/TXK5K'\(?\>D7^[_4UL5)JM@HHHH&%%%% !1110 4444 %%%%
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M&(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7ER]AU%%%=)RA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 -VUY;XUTC^SYRP^Y+\P^IX(_ _H17J=8/C#1_[2@(4?.F67\.
MH_&A$R5SRJBC%%49A1110 4444 %%%% &OX4U8:;.KG[K<-]#P#^!YKUL-FO
M#:]3\&:M]OMP"<O'\K?T/XBDRX,Z&BBBD6%%%% !1110 4444 %%%% !4<D8
M?Y3T-24AH \G\6:"=)E^4?NY"2I'ZC\*Q#7LFKZ2FJQF%^AZ>H(Z&O)M4TQ]
M-D,,G##OV([$?7_ZW8TTS.42I1113)"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]!^&?^KE_WQ_*O
M/J]!^&?^KE_WQ_*AE0W.SHHHJ30**** "BBB@ HHHH **** "BBB@ K!\<?\
M><O_  #_ -#6MZL'QQ_QYR_\ _\ 0UH$]CRDT4&BF9!1113 **** "MWP/\
M\?D7_ __ $!JPJW? _\ Q^1?\#_] :@:W/5Z***DU/"Z***HQ"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***T='T";53B->.['A1^//Y=: 6I0BC,Q"J"23@ =:] \.>!A;;9Y^7'
M(7^$?7U/Z5JZ!X7CTD9'S2$<N1^@]!_/N:VRN:39HHBXI:**104444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !32G>G44 <QXI\*+J@\V/B8?DV.@
M/H?0UYK<0-;L8W!# X(/^?R]:]OQ61KWAR/6%PW#@<,.OT/J*:9$HGDE%:FL
M^'9M*/SC*]F7E?\ ZQ]CCVSUK+_STID:H**** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 )BD*YIU% 'DGBW2/[-G8
M81_F7TP3R/P-8U>F^.-(-]!O49>(EOJ/XA_(_A7F7\JI&35F%%%% @HHHH *
M*** "M[P9J_]GS@'[DHVGT'/!_/]*P:.E ;'N:G-+69X9O3>VT<IZE<'ZJ2I
M_E6G4FP4444 %%%% !1110 4444 %%%% #2*R]>T%-838PPR\JW<'_ ]Q6M3
M=N: /&=5TJ337,4HP>Q[$>H/?^?K[TZ]GU+28]10Q2KD?J/<'_.>]>=:]X+E
MT[+QY>/U Y'U'I[C\J:9FXG.T4#_ #_GM_GBBF2%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7H/PS_U<O\
MOC^5>?5Z#\,_]7+_ +X_E0RH;G9T445)H%%%% !1110 4444 %%%% !1110
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M_P!Z3_OI?_B*/^%;6_\ >D_[Z7_XBBX<AYO17I'_  K:W_O2?]]+_P#$4?\
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MY/(SS7%&*]*_X5Q;>K_FO_Q-'_"N+;U?\U_^)HN'(SS7% %>E?\ "N+;U?\
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M]7_-?_B:/^%<6WJ_YK_\31<.1GFN*,5Z5_PKBV]7_-?_ (FC_A7%MZO^:_\
MQ-%PY&>:XHQ7I7_"N+;U?\U_^)H_X5Q;>K_FO_Q-%PY&>:XHQ7I7_"N+;U?\
MU_\ B:/^%<6WJ_YK_P#$T7#D9YKBC%>E?\*XMO5_S7_XFC_A7%MZO^:__$T7
M#D9YKBC%>E?\*XMO5_S7_P")H_X5Q;>K_FO_ ,31<.1GFN*,5Z5_PKBV]7_-
M?_B:/^%<6WJ_YK_\31<.1GFN*,5Z5_PKBV]7_-?_ (FC_A7%MZO^:_\ Q-%P
MY&>:XHQ7I7_"N+;U?\U_^)H_X5Q;>K_FO_Q-%PY&>:XHQ7I7_"N+;U?\U_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 12, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 12,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Denali Therapeutics Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-3872213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">161 Oyster Point Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">866-8547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DNLI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001714899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="dnli-20260612.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.denalitherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="dnli-20260612.htm">dnli-20260612.htm</File>
    <File>dnli-20260612.xsd</File>
    <File>dnli-20260612_lab.xml</File>
    <File>dnli-20260612_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dnli-20260612.htm": {
   "nsprefix": "dnli",
   "nsuri": "http://www.denalitherapeutics.com/20260612",
   "dts": {
    "inline": {
     "local": [
      "dnli-20260612.htm"
     ]
    },
    "schema": {
     "local": [
      "dnli-20260612.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "dnli-20260612_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dnli-20260612_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.denalitherapeutics.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dnli-20260612.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dnli-20260612.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.denalitherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001714899-26-000081-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001714899-26-000081-xbrl.zip
M4$L#!!0    ( #9@TEQQ7)?1O1(  -2    1    9&YL:2TR,#(V,#8Q,BYH
M=&WM75MSXS:R?L^OP%'V9.PJDR*INVQK2Y'EC#8SMDOR)-GS<@HD(0L9BN0
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MHV)2M1VXT]:1RZ^)C*8>.RZX7(8>G3;]P&?0 3YI8D8FDC^YZS)?_0GI9["
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MV<'\C@==PU"ZA'Q*ZK%U#\#K7\>76\6E[#-0'TF<6,).!/"+T<>"24A,M.4
M9EN@@<#Q[H(#4PY4/H(_4:UQ1&-_?E-K'CM(9&S_C8XO$'^FHQX?\VA1!Y4Y
M01.:+]A8=62QW*Q/V41 =UV>=FL>\YZ8*"%/UQ4J(1.PU):"'^DL>!P&E 35
MI";,_,3X(Q61-G!@4];Z^"Y_0-IHI KH!^F-E;ZCU!;\4K7J6U4(6*OL*D Q
MN$PZ@H>+PMJB+6[ I+(- 7W50V4P239+[#\&)J92"4F^Q7@+:N'M&;S-)QB
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MQ?T]._P_V45O."SX<O '4$L#!!0    ( #9@TEP/R_Z3*0D  'U4   5
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M_#IUA"Q( L^#Q(J=($Q18H7*UZD'E:;IIEP<M-6U+V$/UTNUN^ZA"D9=5K\
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M,#(V,#8Q,BYX<V102P$"% ,4    "  V8-)<#\O^DRD)  !]5   %0
M        @ &!%0  9&YL:2TR,#(V,#8Q,E]L86(N>&UL4$L! A0#%     @
M-F#27/)DG%;G!0  \C   !4              ( !W1X  &1N;&DM,C R-C V
M,3)?<')E+GAM;%!+ 0(4 Q0    ( #9@TESP-B:ABQ$  -L_   ?
M      "  ?<D  !P<F5S<W)E;&5A<V5D871E9&IU;F4Q.#(P,C8N:'1M4$L%
3!@     %  4 40$  +\V      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>dnli-20260612_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dnli-20260612.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001714899</identifier>
        </entity>
        <period>
            <startDate>2026-06-12</startDate>
            <endDate>2026-06-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001714899</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2026-06-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Denali Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38311</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">46-3872213</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">161 Oyster Point Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">866-8547</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">DNLI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
